LaunchPort’s Managing Partner Bob Storey joins Annoviant Advisory Board
Robert (Bob) Storey is the Managing Partner of The LaunchPort™ in Baltimore, Maryland, an innovative for-profit venture center for early-stage medical device companies entering the regulatory approval process and preparing for commercial adoption. He is also appointed as Vice Chairman to the State of Maryland’s Life Sciences Advisory Board and has been active in efforts of collaboration between the FDA, Payors, Device companies and Providers to develop a high value medical device demonstration hub in the Capitol Region.
Mr. Storey currently serves as a Portfolio Executive for the National Institutes of Health Rapid Acceleration of Diagnostics (RADx) investment initiative dealing with the US’s SARS-CoV-2 testing crisis. He is also the NIH’s Medical Device Expert for the I-Corps @ NIH™ program and has led international cohorts in the Lean Start-up area in Asia/Pacific, Africa, Europe, Middle East, and South America.
As an Executive in Residence for Johns Hopkins University, he serves on the External Advisory Board for the Johns Hopkins Center for Biomedical Innovation and Design, the Strategic Advisory Board for Johns Hopkins Laboratory for Computational Sensing and Robotics, the JHU Applied Physics Lab Technology Commercialization Panel, the Investment Review Committee for the Bisciotti Fund, and is the Director of the Evaluation Core for the newly awarded Neurotech Harbor initiative (an NIH hub award to Johns Hopkins/Howard University – one of two nationwide).
After earning degrees in chemical engineering and chemistry at the University of Arkansas, Mr. Storey joined Exxon Corporation in Houston, where he worked in performance materials technology, business planning, mergers, and acquisitions for close to 15 years. He was an advisor in Exxon’s Corporate Controller organization, held Sales and Marketing management positions, and crafted the formation of Exxon Chemical’s international joint venture with Mitsubishi Petrochemical. Mr. Storey left Exxon to become General Manager of a privately held engineering company in Maryland. He led the company through a successful sale to Clariant Corporation of Switzerland, where he served as Vice President of Clariant’s Performance Products division.
Following Clariant, Mr. Storey led Vapotherm, Inc. (NYSE: VAPO), a medical device company that specialized in non-invasive respiratory devices, as founding President and CEO. While with the firm for over a dozen years, he received the U.S Commerce Department’s Export Achievement Award, the Maryland World Trade Center International Leadership Award, and Deloitte’s Technology National Fast 500 award four times.
“We’re excited to welcome Bob and the experience he brings to the Annoviant team and look forward to the significant contributions he will make in his role as Business Advisor” said Ajay Houde, Ph.D. MBA, CEO & Co-Founder at Annoviant.